drugset
drugset / Trial / NCT05696392

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

NCT05696392 ↗

Phase 4 Terminated 47 enrolled Incyte Corporation
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the effect of ruxolitinib cream on sleep disturbances with participants with Atopic Dermatitis.

Timeline

Start
2023-03-16
Primary completion
2025-01-22
Completion
2025-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Ruxolitinib Small molecule 1.5 % Topical

Indications

atopic eczema